Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Fusion-VAC-XS15 |
Trade Name | |
Synonyms | |
Drug Descriptions |
Fusion-VAC-XS15 is a personalized vaccine comprising peptides derived from the DNAJB1-PRKACA fusion protein, which potentially enhances antitumor immune response (PMID: 36302754). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Fusion-VAC-XS15 | Atezolizumab Fusion-VAC-XS15 | 0 | 1 |
Fusion-VAC-XS15 | Fusion-VAC-XS15 | 0 | 1 |